Holland & Barrett reinstates CBD products after sales hiatus

Holland & Barrett has ended the temporary pause on the sale of certain CBD products in its stores and online.

The natural products retailer confirmed to The Grocer that it has reinstated all 31 products it removed last week following the FSA’s decision to reduce your acceptable daily intake CBD tips seven times, at 10 mg.

It added, however, that it publishes shelf-side and product information advisory information on its website for products for which a single serving exceeds the FSA ADI.

As a responsible retailer, we always act with our customers’ best interests at heart. “That’s why we temporarily removed certain products from sale while our scientific, legal and independent advisors evaluated the new FSA guidelines,” a Holland & Barrett spokeswoman said. We wanted to ensure we could help customers make an informed choice about the dosage and length of time they take CBD.

In line with FSA guidance, we have now developed advice, colleague training, online advice and on-shelf information, meaning customers can access the information they need when choosing concentration that suits them.

We are committed to working with the FSA and the industry as a whole for the benefit of our customers as the CBD market continues to grow. We would like to thank our suppliers for their support during the completion of this review.

The statement accompanying CBD products on the Holland & Barrett website reads: The Food Standards Agency (FSA) recommends a daily CBD intake of 10 mg (for a 70 kg adult) for products with a purity of 98%.

This FSA advisory is preventative and concerns long-term sustained use of CBD.

Holland & Barrett recommends that customers check labels and consider their daily CBD intake and the length of time they choose to take CBD, based on this updated advice from the FSA.

James Edmunds, managing director of the CBD Trip brand, welcomed the news.

We are delighted that Holland & Barrett has lifted their temporary pause on the sale of CBD, he said. We look forward to continuing to collaborate with retail partners and regulators to prioritize consumer safety and provide clarity to customers.

Edmunds said Trip recorded its best sales week ever for the week ending October 15. [NIQ]. This, he said, demonstrates the strength of demand for its products.

Brits continue to choose Trip CBD products to support their daily wellbeing, having seen their benefits over recent years, he added.

Other products that have been reinstated include CBDfx gummies and Unroote shots.

CBDfx Managing Director Carlo Buckley said the brand was very pleased to have been reinstated, adding that it was on track to record its best sales quarter to date.

“We now look forward to working closely with the FSA to understand the wider implications of this announcement for all stakeholders in the supply chain, including consumers who are at the heart of everything we do,” he said. -he adds.